from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0838/lpqR

LFCtreatmentdescriptionclass of inhibitor

-0.992

Amikacinug/mL Amikacintranslation

-1.276

Cap5-10ug/mL Capreomycintranslation

-1.586

Rox10-50 ug/mL Roxithromycintranslation

0.036

SM2-5 ug/mL Streptomycintranslation

-1.390

Tet5-10 ug/mL Tetracyclinetranslation

-1.023

Rif0.2-5ug/mL Rifampicintranscription

-0.207

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.349

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.052

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.328

CPZ10-50 ug/mL Chlorpromazinerespiration

0.281

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.571

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.206

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.289

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.312

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.849

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.784

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.567

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.157

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.628

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.040

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.243

Nigericin50 uM Nigericinrespiration

-0.914

TRC10-150 ug/mL Triclosanrespiration

2.135

TRZ10-25 ug/mL Thioridazinerespiration

0.061

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.515

menadione6-10 ug/mL Menadionerespiration

0.228

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.262

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.466

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.158

NRP_1Non-replicating persistence stage 1dosRassociated

0.327

Amp0.2mg/mL AmpicillincellWall

0.427

Cephalexin20-100 ug/mL CephalexincellWall

0.568

Cerulenin0.32-5 ug/mL CerulenincellWall

0.026

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.263

EMB10-20 ug/mL EthambutolcellWall

0.094

Eta12-40 ug/mL EthionamidecellWall

0.075

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.380

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.241

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.654

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.240

BZA0.12 mg/mL BenzamidearomaticAmides

-0.642

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.222

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.224

H2O24 mM hydrogen peroxideDNAdamaging

-0.040

Levo10 ug/mL LevofloxacinDNAdamaging

0.395

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.477

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.143

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.707

UVUV-irradiationDNAdamaging

0.695

ARP41-4 ug/mL Antitubercular compound ARP4?

0.068

Antimycin12.5-50 ug/mL Antimycin A?

1.232

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.035

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.161

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.700

PA8240.2-2 ug/mL PA-824?

0.874

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.798

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.076

Verapamil50 uM Verapamil?

0.055

mercaptoethanol2 mM 2-Mercaptoethanol?

0.147

methoxatin10-20 ug/mL Methoxatin?